Knowledge, attitudes, and perception towards human papillomavirus among university students in Pakistan Fulltext Access 6 Pages 2016
Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data Fulltext Access 5 Pages 2016
Ethnic background and human papillomavirus vaccine uptake in Denmark: A countrywide retrospective cohort study including 274,154 women aged 19-28 years Fulltext Access 7 Pages 2016
Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts Fulltext Access 6 Pages 2016
What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States? Fulltext Access 6 Pages 2016
HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection Fulltext Access 4 Pages 2016
High specific immune response to a bivalent anti-HPV vaccine in HIV-1-infected men in São Paulo, Brazil Fulltext Access 4 Pages 2016
Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men Fulltext Access 9 Pages 2016
Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme? Fulltext Access 5 Pages 2016
Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study Fulltext Access 8 Pages 2016
HPV vaccination intention among male clients of a large STI outpatient clinic in Amsterdam, the Netherlands Fulltext Access 7 Pages 2016
Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy Fulltext Access 8 Pages 2016
Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccines Fulltext Access 5 Pages 2016
Healthcare providers’ beliefs and attitudes regarding risk compensation following HPV vaccination Fulltext Access 6 Pages 2016
Monitoring the impact of HPV vaccine in males—Considerations and challenges Fulltext Access 6 Pages 2016
HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US Fulltext Access 8 Pages 2016
Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico Fulltext Access 8 Pages 2016
The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines Fulltext Access 8 Pages 2016
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region Fulltext Access 9 Pages 2016
Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women Fulltext Access 5 Pages 2016
HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005 Fulltext Access 5 Pages 2016
Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples Fulltext Access 7 Pages 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation Fulltext Access 10 Pages 2016
HPV vaccination initiation after the routine-recommended ages of 11–12 in the United States Fulltext Access 6 Pages 2016